🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder. Alth...
Status
Completed
Location
4th Department of Internal Medicine, ATTIKON University Hospital
Start Date
2015-12
Trial ID
NCT02643654
This study is designed to evaluate the safety, tolerability, and immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01444352
This is a Phase 1a, first in human study in which healthy adult participant...
Status
Completed
Location
Investigative Site
Start Date
2020-12-28
Trial ID
NCT04725877
The purpose of this study is to assess the safety and tolerability of intra...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-21
Trial ID
NCT02440035
Treatments Being Tested
Evaluation of NLA Nasal Spray with regard to taste perversion and local tol...
Status
Completed
Location
Department of Otorhinolaryngology, Lund University Hospital
Start Date
2007-09
Trial ID
NCT00533637
The objective of this trial was to assess the efficacy, safety, and PK/PD e...
Status
Completed
Location
University of Sydney Brain and Mind Centre
Start Date
2019-12-19
Trial ID
NCT04098406
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Karolinska University Hospital
Start Date
2010-08
Trial ID
NCT01188512
The purpose of this study is to determine whether vaccination with NicVAX w...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2006-05
Trial ID
NCT00318383
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of VitroGr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT01982318
Treatments Being Tested
Study SYNB8802-CP-002 is designed to assess safety, tolerability, and oxala...
Status
Completed
Location
PPD, part of Thermo Fisher Scientific
Start Date
2022-03-29
Trial ID
NCT05377112
Treatments Being Tested